| Consolidated income statement | |||||
|---|---|---|---|---|---|
| 2011 52 weeks ended 30-Dec-11 |
2010 52 weeks ended 31-Dec-10 |
2009 52 weeks ended 1-Jan-10 |
2008 53 weeks ended 2-Jan-09 |
2007 52 weeks ended 28-Dec-07 |
|
| $’000 | $’000 | $’000 | $’000 | $’000 | |
| Results | |||||
| Turnover / revenue | 845,190 | 800,608 | 601,399 | 694,865 | 848,622 |
| Operating profit (loss) | (48,365) | (6,253) | (15,914 ) | (8,515 ) | 150,098 |
| Profit (loss) before tax | (51,464) | (5,705) | (14,242 ) | (6,451 ) | 155,599 |
| Taxation | 85,330 | 22,331 | 2,933 | (488 ) | (42,795 ) |
| Profit (loss) for the financial year | 33,866 | 16,626 | (11,309 ) | (6,939 ) | 112,804 |
| Assets employed | |||||
| Total assets | |||||
| Non-current assets | 617,068 | 318,191 | 311,317 | 181,773 | 249,296 |
| Net current assets | 312,615 | 505,312 | 465,510 | 307,810 | 267,717 |
| Non-current liabilities | (51,776) | 48,939 | (2,716 ) | (22,837 ) | (8,350 ) |
| Net assets | 877,907 | 774,564 | 774,111 | 466,746 | 508,663 |
| Authorised share capital (£'000) | 350,000 | 350,000 | 350,000 | 185,000 | 185,000 |
| Number of shares outstanding (number) | 215,667,851 | 184,953,312 | 182,187,878 | 132,890,821 | 132,072,576 |
| $ | $ | $ | $ | $ | |
| Key statistics | |||||
| Earnings (loss) per share | 0.19 | 0.09 | (0.07 ) | (0.05 ) | 0.86 |
| Diluted earnings (loss) per share | 0.19 | 0.09 | (0.07 ) | (0.05 ) | 0.83 |
Underlying Five Year Financial Summary
|
$’000 | $’000 | $’000 | $’000 | $’000 |
| Revenue | 845,190 | 800,608 | 601,399 | 694,865 | 848,622 |
| Underlying gross margin | 49.8% | 47.7% | 44.6% | 44.6% | 46.7% |
| Underlying operating expenses | 371,940 | 303,265 | 241,367 | 236,998 | 215,013 |
| Underlying operating income | 49,206 | 78,976 | 26,933 | 72,830 | 181,261 |
| Underlying net income | 36,808 | 77,371 | 30,728 | 64,230 | 137,484 |
| $ | $ | $ | $ | $ | |
| Underlying net income per diluted share | 0.20 | 0.43 | 0.20 | 0.49 | 1.01 |
Non GAAP Disclosure. Although IFRS disclosures provide investors with an overall view of CSR’s performance, CSR also provides underlying line item disclosure. CSR believes that these underlying items (in particular, underlying gross margin, underlying R&D expenditures and underlying SG&A expenditure, and operating profit, operating margin and earnings per share derived therefrom) provide additional information on underlying trends that is useful to investors. Management uses these underlying measures, along with the most directly comparable IFRS financial measures, to assess CSR’s operating performance and value creation. These underlying measures form the basis for management’s performance targets and resource allocation decisions, and are also used to determine and manage the long term growth of the business. We present and discuss these measures in order to: (a) provide consistency with the way management views the business and discuss performance with investors; (b) ensure that the measures are fully understood in the light of how CSR manages the business; (c) properly define the metrics used and confirm their calculation; (d) share the metrics with all investors at the same time; (e) improve transparency for investors; (f) assist investors in their assessment of the long-term value of CSR; and (g) assist investors in understanding management behaviour. The term “underlying” is not defined in IFRS, and may therefore not be comparable with similarly titled measures reported by other companies. Underlying measures should not be considered in isolation from, as substitutes for, or as superior measures to, IFRS measures. Underlying results add back charges for amortisation of acquired intangibles assets, share option charges, integration and restructuring charges, acquisition costs and certain other
